Gts Securities »

Arbutus Biopharma shares owned by Gts Securities

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $121k 48k 2.50
2023-09-30 $23k 11k 2.03

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding Arbutus Biopharma

Whitefort Capital Management
Vanguard Group
Hudson Bay Capital Management
ADAR1 Capital Management
Centiva Capital
Citadel Advisors
Millennium Management
Advisor Group Holdings
FourWorld Capital Management
Citigroup
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Barclays
Bank Of Montreal

View all funds holding Arbutus Biopharma